4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-20-053260
Chief Business Officer sold 6,945 shares at $34.75 ($241,342)
- Chief Business Officer acquired 6,945 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Parrish Jay Chief Business Officer | 2020-10-01 | Option exercise | +4,630 | $1.49 | $6,876 | 226,852 | D |
| Parrish Jay Chief Business Officer | 2020-10-01 | Option exercise | +2,315 | $1.58 | $3,646 | 229,167 | D |
| Parrish Jay Chief Business Officer | 2020-10-01 | Sale | −6,945 | $34.75 | $241,342 | 222,222 | D |
| Derivatives | |||||||
| Parrish Jay Chief Business Officer | 2020-10-01 | Option exercise · Stock Option (Right to Buy) | −4,630 | 32,407 | D | ||
| Parrish Jay Chief Business Officer | 2020-10-01 | Option exercise · Stock Option (Right to Buy) | −2,315 | 50,926 | D | ||
| Open-market sales · 6,945 sh · avg $34.75 · $241,342 | |||||||
Loading xslF345X03/doc4.xml…